Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on June 21, 2016, to report a corporate event under Item 8.01 Other Events. The company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused on a specific corporate announcement rather than periodic financial performance.
Material Changes
The material event reported is the issuance of a press release on June 21, 2016, disclosing a new patent application. The application utilizes stem cell technology intended for the treatment of recurrent pregnancy loss.
Guidance, Outlook, and Risks
The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of the filing date. Management warns that actual results could differ materially from anticipated outcomes due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. The Company assumes no obligation to update these statements unless required by law.
Investor Verification Checklist
- Verify the status and scope of the new stem cell patent application referenced in the June 21, 2016 press release.
- Review the risk factors detailed in the Form 10-K for the year ended December 31, 2015, to understand potential obstacles to the technology's development.
- Confirm the current financial position of the company through its most recent periodic reports, as this 8-K contains no financial data.